"地域の医療機関と密接な連携をとりながら、急性期を中心に、高度な医療を一貫して提供しています。 外来では、救急やほかの医療機関からの紹介診療をはじめとする多彩な診療を行い、インターチェンジ近くに立地する利点を生かして、救急や遠方からの患者さんの受け入れ態勢を充実させています。"

During the past decade, Rakuwakai Otowa Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rakuwakai Otowa Hospital" #1 sponsor was "Pfizer" with 6 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rakuwakai Otowa Hospital" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rakuwakai Otowa Hospital" are "Alzheimer Disease" (6 trials), "COVID-19" (2 trials), "Atrial Fibrillation" (1 trials), "Cognitive Dysfunction" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Rakuwakai Otowa Hospital" in a lesser frequency.

Most popular intervention types in "Rakuwakai Otowa Hospital" are "Drug" (14 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Gantenerumab" (2 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "bapineuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rakuwakai Otowa Hospital" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Rakuwakai Otowa Hospital". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Rakuwakai Otowa Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Rakuwakai Otowa Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Rakuwakai Otowa Hospital has several departments that took part in Clinical trials: "Sobajima Clinic/Orthopedics" - 2 trials